BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34804030)

  • 1. Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine.
    Joshi LR; Knudsen D; Piñeyro P; Dhakal S; Renukaradhya GJ; Diel DG
    Front Immunol; 2021; 12():747574. PubMed ID: 34804030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.
    do Nascimento GM; de Oliveira PSB; Butt SL; Diel DG
    Front Immunol; 2024; 15():1322879. PubMed ID: 38482020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Asthagiri Arunkumar G; McMahon M; Pavot V; Aramouni M; Ioannou A; Lambe T; Gilbert S; Krammer F
    Vaccine; 2019 Sep; 37(37):5567-5577. PubMed ID: 31399277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs.
    Tang P; Cui E; Cheng J; Li B; Tao J; Shi Y; Jiao J; Du E; Wang J; Liu H
    Front Immunol; 2024; 15():1361323. PubMed ID: 38835763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.
    McCormick K; Jiang Z; Zhu L; Lawson SR; Langenhorst R; Ransburgh R; Brunick C; Tracy MC; Hurtig HR; Mabee LM; Mingo M; Li Y; Webby RJ; Huber VC; Fang Y
    PLoS One; 2015; 10(6):e0127649. PubMed ID: 26061265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of a polyvalent influenza DNA vaccine in pigs.
    Karlsson I; Borggren M; Rosenstierne MW; Trebbien R; Williams JA; Vidal E; Vergara-Alert J; Foz DS; Darji A; Sisteré-Oró M; Segalés J; Nielsen J; Fomsgaard A
    Vet Immunol Immunopathol; 2018 Jan; 195():25-32. PubMed ID: 29249314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs.
    Opriessnig T; Gauger PC; Filippsen Favaro P; Rawal G; Magstadt DR; Digard P; Lee HM; Halbur PG
    Vaccine; 2024 Jan; 42(2):220-228. PubMed ID: 38087714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.
    Wilson JR; Tzeng WP; Spesock A; Music N; Guo Z; Barrington R; Stevens J; Donis RO; Katz JM; York IA
    Virology; 2014 Jun; 458-459():114-24. PubMed ID: 24928044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade influenza A virus in swine.
    Thomas MN; Zanella GC; Cowan B; Caceres CJ; Rajao DS; Perez DR; Gauger PC; Vincent Baker AL; Anderson TK
    J Virol; 2024 Mar; 98(3):e0170323. PubMed ID: 38353535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge.
    Reneer ZB; Bergeron HC; Reynolds S; Thornhill-Wadolowski E; Feng L; Bugno M; Truax AD; Tripp RA
    PLoS One; 2024; 19(4):e0297833. PubMed ID: 38635725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swine influenza A virus: challenges and novel vaccine strategies.
    Petro-Turnquist E; Pekarek MJ; Weaver EA
    Front Cell Infect Microbiol; 2024; 14():1336013. PubMed ID: 38633745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Brogaard L; Heegaard PMH; Larsen LE; Skovgaard K
    Virology; 2024 Aug; 596():110117. PubMed ID: 38797064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Nanoparticle-Mediated Delivery of Recombinant Influenza Hemagglutinin Enhances Immunogenicity and Breadth of the Antibody Response.
    Badten AJ; Ramirez A; Hernandez-Davies JE; Albin TJ; Jain A; Nakajima R; Felgner J; Davies DH; Wang SW
    ACS Infect Dis; 2023 Feb; 9(2):239-252. PubMed ID: 36607269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    Ma W; Loving CL; Driver JP
    J Immunol; 2023 Oct; 211(8):1187-1194. PubMed ID: 37782856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
    Rijnink WF; Stadlbauer D; Puente-Massaguer E; Okba NMA; Kirkpatrick Roubidoux E; Strohmeier S; Mudd PA; Schmitz A; Ellebedy A; McMahon M; Krammer F
    J Virol; 2023 Nov; 97(11):e0164622. PubMed ID: 37916834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation.
    Yang SW; Jang YH; Kwon SB; Lee YJ; Chae W; Byun YH; Kim P; Park C; Lee YJ; Kim CK; Kim YS; Choi SI; Seong BL
    FASEB J; 2018 May; 32(5):2658-2675. PubMed ID: 29295864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing.
    Oxford JS
    Br J Clin Pharmacol; 2013 Aug; 76(2):210-6. PubMed ID: 23617282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior infection with unrelated neurotropic virus exacerbates influenza disease and impairs lung T cell responses.
    Foo IJ; Chua BY; Clemens EB; Chang SY; Jia X; McQuilten HA; Yap AHY; Cabug AF; Ashayeripanah M; McWilliam HEG; Villadangos JA; Evrard M; Mackay LK; Wakim LM; Fazakerley JK; Kedzierska K; Kedzierski L
    Nat Commun; 2024 Mar; 15(1):2619. PubMed ID: 38521764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of an NP-hoc fusion protein: Utilizing influenza a nucleoprotein and phage T4 hoc protein.
    Balderas-Cisneros FJ; León-Buitimea A; Zarate X; Morones-Ramírez JR
    Protein Expr Purif; 2024 Sep; 221():106506. PubMed ID: 38772430
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Reguzova A; Ghosh M; Müller M; Rziha HJ; Amann R
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32531997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.